Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate for diffuse sclerosing osteomyelitis of the mandible
jRCTs051180011Active, not recruiting
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of zoledronate in Diffuse sclerosing osteomyelitis of the jaw (DSO). Primary endpoint: Mandibular pain VAS at 1 year. Started Sep 2018; status: active, not recruiting.
02
Drugs
zoledronate
03
Conditions
Diffuse sclerosing osteomyelitis of the jaw (DSO)
Beyond the preview
Go deeper on jRCTs051180011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180011.